PPPD continues to provoke debate since the diagnostic criteria emerged in 2017. This review covers two commentaries because they are best considered together: the first one, by HK and BS-U, concluded that PPPD is a psychosomatic disorder (in fact, ‘a...
Neuromod Devices has launched its Lenire tinnitus treatment device in the United Kingdom, where it is estimated that seven million people suffer from tinnitus.
Neuromod Devices has announced the formation of a global commercial leadership team to further commercialise its Lenire tinnitus treatment device through key partnerships.
30 April 2020
| Jiao Xia, Shusheng Gong (Prof)
|
ENTA - General
In January, we first heard of COVID-19. As we currently do battle with it on our own shores, colleagues in China share their story with us as life there slowly and cautiously begins to return to normal and the country...
John Fenton, Republic of Ireland, has recently been appointed President of the Union Européene Des Médicins Spécialistes (UEMS) ORL or European Union of Medical Specialists ORL Section. We caught up with him to find out a little more about his...
The BTA and Evergreen PR launched the Tinnitus Manifesto with support from politicians, academics and people with tinnitus. The campaign has attracted more than…
ENT & Audiology News is delighted to have a presence at this month’s 44th Annual Conference of the Association of Otolaryngologists of India, Delhi State.
For nearly 50 years, the TWJ has made awards ranging from international fellowships in research and education to support for training and smaller grants for otology-related activities.
A number of significant steps forward in person-centred care have taken place in China. The Person-centred Care Hearing Research Center (PCCHRC) was established in Xuzhou Medical University in China on 18 April 2025. At the same time, the PCC Alliance...
The Confederation of the European Otorhinolaryngology and Head and Neck Surgery
(CEORL-HNS) is offering 20 Observership Travel Grants for young ENT professionals aged 35 and under.